APIs for research and impurities

<p>This is a metabolite of guaifenesin, and it is an impurity in the EP guaifenesin. It can be custom synthesized for research and development purposes. The purity of this product is high, and it can be used as an analytical standard or a drug product.</p>

<p>Decitabine impurity 14 is an impurity of decitabine. It is a stable, natural product that has been synthesized for use as an analytical standard and pharmacopoeia reference material. Decitabine impurity 14 is a white crystalline powder with a melting point of about 152°C. It is soluble in water, ethanol and ether. The chemical name for this compound is 2-amino-4,6-dihydroxypyrimidine-5-carbonitrile hydrochloride.</p>

<p>Cetirizine metabolite</p>

<p>Tacrolimus is a macrolide that is used as an immunosuppressive drug. It has been shown to bind to the FK-binding protein, which in turn inhibits calcineurin. This prevents the release of IL-2, TNF-α and other cytokines. The immunosuppressive effects of tacrolimus have been evaluated using analytical methods such as coefficients, affinity, and monitoring techniques such as immunoassays and agglutination. These techniques are used to evaluate the plasma concentration of tacrolimus. Tacrolimus also binds to proteins in the blood samples and can be detected by turbidimetric or electrochemiluminescence immunoassay reagents.</p>

<p>Olmesartan is a drug that belongs to the class of angiotensin II receptor antagonists. It is used for the treatment of high blood pressure, heart failure, and kidney disease. The therapeutic effect of olmesartan can be increased by concomitant use with other drugs if it is being used as a combination therapy. This drug interacts with many other drugs, including diuretics and ACE inhibitors. Drugs that are known to interact with olmesartan include furosemide, hydrochlorothiazide, amiloride, spironolactone, triamterene, chlorothiazide and quinethazone. Blood sampling is often required during therapy in order to monitor the efficacy of this drug.</p>

<p>S(-)-BZM is a potent kinase inhibitor that has been shown to induce apoptosis in cancer cells. It is an analog of the natural product staurosporine and has been isolated from human urine. S(-)-BZM inhibits the activity of several kinases, including protein kinase C and cyclin-dependent kinases, which are involved in cell cycle regulation and tumor growth. This drug has been tested on various cancer cell lines, including leukemia, and has demonstrated significant antitumor activity. S(-)-BZM is a promising medicinal agent for the treatment of cancer and other diseases characterized by abnormal cell proliferation.</p>

<p>Please enquire for more information about Acrolein-d4 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Bezafibrate is a drug product that is used in the treatment of hyperlipidemia. It is an impurity standard for bezafibrate 1-o-β-glucuronide, which can be used as an analytical standard for HPLC analysis. Bezafibrate 1-o-β-glucuronide can also be used to evaluate the metabolism of bezafibrate through animal studies.</p>

<p>Please enquire for more information about 2-Desmethylene-2-chloromethyl ethacrynic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>